Search Nonprofits

UMDF's mission is to promote research and education for the diagnosis, treatment and cure of mitochondrial disorders and provide support to affected individuals and families.

The mission of The Lustgarten Foundation is to advance the scientific and medical research related to the diagnosis, treatment, cure and prevention of pancreatic cancer; and to provide patients and families with the information they need to make informed decisions about their care.

Food Allergy Research & Education (FARE) works on behalf of the 15 million Americans with food allergies, including all those at risk for life-threatening anaphylaxis. This potentially deadly disease affects 1 in 13 children in the United States – or roughly two in every classroom. FARE is a 501(c)(3) nonprofit organization that was formed in 2012 as the result of a merger between the Food Allergy & Anaphylaxis Network and the Food Allergy Initiative. FARE’s mission is to ensure the safety and inclusion of individuals with food allergies while relentlessly seeking a cure.

Our mission is to find a effective treatments and ultimately a cure for fragile X syndrome, the most common inherited cause of autism. We directly fund research grants and fellowships at top universities around the world. FRAXA was founded in 1994 by three parents of children with fragile X. Fragile X Syndrome is the most common inherited cause of autism and intellectual disabilities. It affects 1 in 4000 boys and 1 in 6000 girls worldwide, and one in 260 women and 1 in 800 men are carriers. Treatments for fragile X are likely to help people affected by related disorders including autism, Alzheimers, and many other brain disorders.

The BlinkNow Foundation’s mission is to provide an education and a loving, caring home for orphaned, impoverished and at-risk children. We also provide community outreach to reduce poverty, empower women, improve health, and encourage sustainability and social justice. The Foundation fulfills its mission by providing financial support and management oversight to the Children’s Home and Kopila Valley School in Surkhet, Nepal.

Cure SMA leads the way to a world without spinal muscular atrophy, the number one genetic cause of death for infants. We fund and direct comprehensive research that drives breakthroughs in treatment and care, and we provide families the support they need for today.

The mission of Southeastern Guide Dogs is to create and nurture a partnership between a visually impaired individual and a guide dog, facilitating life's journey with mobility, independence and dignity.

The Pacific Mesothelioma Center at the Pacific Heart, Lung and; Blood Institute’s mission is to better serve a growing number of mesothelioma victims by supporting the first-of-its-kind in the nation research lab which provides laboratory-to-the-bedside research that improve mesothelioma victims’ lives and longevity, particularly for those that approach malignant pleural mesothelioma (MPM) as a chronic, treatable disease: The exploration of innovative ideas forms the foundation of PMC’s unique research program and provides the promise of future treatment breakthroughs. With the opening of our new laboratory at 10780 Santa Monica, dedicated solely to mesothelioma research, and by choosing specific projects, we will get closer to finding better treatments and research that we hope will eventually lead to a cure. PMC is dedicated to educating the public on asbestos-related diseases and informing them of their best treatment options. PMC also connects newly diagnosed patients with patients that have been through treatment and provides assistance and emotional support.

Vitamin Angels reduces child mortality worldwide by connecting essential micronutrients with infants and children under five. Essential nutrients, especially vitamin A, help young immune systems fight infectious diseases, helping children attain good health and the opportunity to lead meaningful and productive lives.

The Children's Tumor Foundation is a not-for-profit organization dedicated to finding effective treatments for the millions of people worldwide living with neurofibromatosis (NF), a term for three distinct disorders: NF1, NF2, and schwannomatosis.  NF causes tumors to grow on nerves throughout the body and can lead to blindness, bone abnormalities, cancer, deafness, disfigurement, learning disabilities, and excruciating and disabling pain.   NF affects one in every 3,000 people, more than cystic fibrosis, Duchenne muscular dystrophy, and Huntington’s disease combined.  The Children’s Tumor Foundation funds critical research into neurofibromatosis.  In addition to benefiting those who live with NF, this research is shedding new light on several forms of cancer, brain tumors, bone abnormalities, and learning disabilities, ultimately benefiting the broader community.

The Community Hospice is a non-profit 501(c)(3) organization, accredited by the Community Health Accreditation Program. We are part of St. Peter's Health Partners, and are privileged to work with every hospital in the region to provide hospice services. We serve more than 4,300 seriously ill patients and their families a year. The elderly, terminally ill and dying are among the most vulnerable people in our society. Incredible advances in medical care and social services haven’t ended the tragedy of people dying alone or in pain. Meeting that need is our mission: The Community Hospice serves seriously ill people and their families during the process of dying and grieving. We enhance quality of life with comprehensive, compassionate services that respect the dignity of those we serve. And we offer that help and comfort in eight counties in upstate New York: Albany, Schenectady, Rensselaer, Saratoga, Columbia, Greene, Montgomery and Washington.

The Multiple Myeloma Research Foundation, Inc. mission is to: relentlessly pursue innovative means that accelerate the development of next-generation multiple myeloma treatments to extend the lives of patients and lead to a cure. To achieve this purpose, four goals are pursued: Funding research in the field of multiple myeloma, building collaborations among researchers and industry, providing disease and treatment related information to patients and family members while advocating for optimal patient care, and raising awareness of multiple myeloma.